Page last updated: 2024-08-20

protocatechualdehyde and molybdenum

protocatechualdehyde has been researched along with molybdenum in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, C; Lü, JM; Yao, Q	1

Other Studies

1 other study(ies) available for protocatechualdehyde and molybdenum

Article	Year
3,4-Dihydroxy-5-nitrobenzaldehyde (DHNB) is a potent inhibitor of xanthine oxidase: a potential therapeutic agent for treatment of hyperuricemia and gout. Biochemical pharmacology, 2013, Nov-01, Volume: 86, Issue:9 Topics: Administration, Oral; Allopurinol; Animals; Antioxidants; Benzaldehydes; Catechols; Cell-Free System; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; Gout Suppressants; Hyperuricemia; Inhibitory Concentration 50; Mice; Mice, Inbred C57BL; Molybdenum; Reactive Oxygen Species; Structure-Activity Relationship; Uric Acid; Xanthine Oxidase	2013

Article

Year

3,4-Dihydroxy-5-nitrobenzaldehyde (DHNB) is a potent inhibitor of xanthine oxidase: a potential therapeutic agent for treatment of hyperuricemia and gout.

Biochemical pharmacology, 2013, Nov-01, Volume: 86, Issue:9

Topics: Administration, Oral; Allopurinol; Animals; Antioxidants; Benzaldehydes; Catechols; Cell-Free System; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; Gout Suppressants; Hyperuricemia; Inhibitory Concentration 50; Mice; Mice, Inbred C57BL; Molybdenum; Reactive Oxygen Species; Structure-Activity Relationship; Uric Acid; Xanthine Oxidase

2013